HEMODIALYSIS-RELATED PORPHYRIA-CUTANEA-TARDA AND TREATMENT BY RECOMBINANT-HUMAN-ERYTHROPOIETIN

被引：22

作者：

YAQOOB, M

SMYTH, J

AHMAD, R

MCCLELLAND, P

FAHAL, I

KUMAR, KAS

YU, R

VERBOV, J

机构：

[1] UNIV HOSP CARDIFF, DEPT BIOCHEM, CARDIFF, WALES

[2] ROYAL LIVERPOOL HOSP, REG RENAL UNIT, LIVERPOOL L7 8XP, MERSEYSIDE, ENGLAND

[3] ROYAL LIVERPOOL HOSP, DEPT DERMATOL, LIVERPOOL L7 8XP, MERSEYSIDE, ENGLAND

来源：

NEPHRON | 1992年 / 60卷 / 04期

关键词：

PORPHYRIA CUTANEA TARDA; HEMODIALYSIS; RECOMBINANT HUMAN ERYTHROPOIETIN;

D O I：

10.1159/000186803

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Haemodialysis-related porphyria cutanea tarda is a rare, but serious and mutilating skin condition, resulting from extremely high plasma porphyrin levels because of their inadequate clearance by haemodialysis. The treatment is very difficult as chloroquine is ineffective and venesection, the conventional treatment of this disease, is not always an option because of anaemia of end-stage renal disease. We report a case of haemodialysis-related porphyria cutanea tarda and her successful management by recombinant human erythropoietin treatment.

引用

页码：428 / 431

页数：4

共 20 条

[1] ERYTHROPOIETIN FOR THE TREATMENT OF PORPHYRIA CUTANEA-TARDA IN A PATIENT ON LONG-TERM HEMODIALYSIS [J].